Phil Morton

Chief Technology Officer • Albumedix

Dr Philip Morton has a strong technology background with over 25 years’ experience in the biopharmaceutical industry within process and product development as well as product application research. He was trained as a biochemical engineer and has biopharmaceutical experience in both R&D and manufacturing environments in Albumedix under its former owners of Delta Biotechnology, Aventis and Novozymes. He current heads up biotechnology innovation within Albumedix in both the production and use of its’ products.

Also Speaking

Becky Cap

Chief Operating Officer, GenCure, Senior Vice President • BioBridge Global

Ryan Cawood

Chief Scientific Officer • WuXi Advanced Therapies

Julia Tarasenko

VP, Commercial Operations, EMEA and Americas • Marken

Event Info


Fun Run